BASi
provides clients with increased sample analysis speed and quick
turnaround with the LDTD technology. Fast screening is combined with
accurate quantification results, to benefit any bioanalytical
studies.
LDTD
(Laser Diode Thermal Desorption) technology is an innovative technique
that introduces all samples into the mass spectrometer by a rapid laser
thermal desorption process, where they are ionized by an atmospheric
pressure chemical reaction (LDTD-APCI) and fully analyzed 10 to 20 times
faster than with current LC-MS/MS systems – without compromising
accuracy. LDTD is an ion source for mass spectrometry, working without
any LC apparatus.
“BASi’s use of LDTD technology can reduce sample analysis time to a
fraction previously required by LC-MS/MS,” stated Tony Chilton, COO,
Scientific Services. “With this new technology we will be able to
provide our clients with another outstanding tool for sample analysis.”
Recently, BASi presented a poster on LDTD
technology at the ASMS Conference on Mass Spectrometry, “Validation of
Pioglitazone in Human Serum by Two Sample Introduction Methods:
LDTD-APCI/MS/MS and LC-ESI/MS/MS.” The poster is available at http://www.basinc.com/library/presentations.html.
About BASi
BASi provides contract research services (preclinical, bioanalytical,
large molecule bioanalysis, method development, pharmaceutical analysis)
and specialized instrumentation and accessories for electrochemistry and
in vivo sampling products to the world’s leading drug development
companies in the US and Europe. The company focuses on developing
innovative services and products that increase efficiency and reduce the
cost of taking new drugs to market. Visit www.BASInc.com
for more information about BASi.
BASi
Alice Schwind, 1-765-497-8458
aschwind@BASInc.com